JENBURKT PHARMACEUTICALS
|
JENBURKT PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Profit Before Tax | ₹44 Cr | ₹35 Cr | ₹33 Cr | ₹30 Cr | ₹22 Cr |
Adjustment | ₹-3.09 Cr | ₹-0.49 Cr | ₹-1.54 Cr | ₹-2.25 Cr | ₹-1.60 Cr |
Changes In working Capital | ₹0.49 Cr | ₹-18 Cr | ₹-6.05 Cr | ₹-11 Cr | ₹5.25 Cr |
Cash Flow after changes in Working Capital | ₹41 Cr | ₹16 Cr | ₹25 Cr | ₹17 Cr | ₹25 Cr |
Cash Flow from Operating Activities | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr | ₹19 Cr |
Cash Flow from Investing Activities | ₹-17 Cr | ₹-0.58 Cr | ₹2.62 Cr | ₹-1.20 Cr | ₹-19 Cr |
Cash Flow from Financing Activities | ₹-7.62 Cr | ₹-7.08 Cr | ₹-21 Cr | ₹-5.53 Cr | ₹-0.71 Cr |
Net Cash Inflow / Outflow | ₹3.24 Cr | ₹0.47 Cr | ₹-1.37 Cr | ₹2.54 Cr | ₹-0.04 Cr |
Opening Cash & Cash Equivalents | ₹4.13 Cr | ₹3.66 Cr | ₹5.03 Cr | ₹2.49 Cr | ₹2.53 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹7.36 Cr | ₹4.13 Cr | ₹3.66 Cr | ₹5.03 Cr | ₹2.49 Cr |
Compare Cashflow Statement of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹612.8 Cr | 5.7% | 21.8% | 55% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,584.0 Cr | 0.5% | 0.6% | 9.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹182,147.0 Cr | 3.7% | 5.1% | 49.1% | Stock Analytics | |
CIPLA | ₹120,941.0 Cr | -1% | 1.7% | 2.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,325.0 Cr | 3.8% | 6.8% | 22.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,138.0 Cr | -3.7% | 1.9% | -0.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | 5.7% |
21.8% |
55% |
SENSEX | 0.8% |
2.5% |
5.3% |
You may also like the below Video Courses